ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1108

Cartilage Biomarkers s-Coll2-1 and s-Coll2-1NO2 Are Associated with Knee Osteoarthritis MRI Features and Predict Disease Worsening

Yves Henrotin1, Anne-Christine Hick2, Berenice Costes3, Alain Labasse3, Thierry Conrozier4, Michel Malaise5, Yves Maugars6, Franz Pelousse7, Jean-Marc Lemaire8, Cedric Tits9, Thibault Helleputte9 and Damien Loeuille10, 1University of Liège, Liège, Belgium, 2Artialis SA, Liège, Belgium, 3Artialis SA, Liege, Belgium, 45. Department of Rheumatology, Hôpital Nord Franche-Comté, Belfort, France, 5University of Liège, Liege, Belgium, 6Service de rhumatologie, Hôtel-Dieu, CHU de Nantes, Nantes, France, 7SODIRAY, Solution Diagnostique Radiologique, Liège, Belgium, 8SODIRAY, Solution Diagnostique Radiologique, Liege, Belgium, 9Data-Driven Precision Medicine, DNAlytics, Louvain-la-Neuve, Belgium, 10CHU NANCY Rheumatology, NANCY

Meeting: ACR Convergence 2020

Keywords: Biomarkers, Cohort Study, Collagen, Magnetic resonance imaging (MRI), Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Osteoarthritis – Clinical Poster I

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: To identify if biochemical markers s-Coll2-1, a peptide of type collagen and its nitrated from, s-Coll2-1NO2 are associated to knee osteoarthritis (OA), focusing on pain, function as well as structural features assessed by MRI and to assess their ability at predicting knee OA worsening.

Methods: 116 subjects with knee OA were followed during one year with pain, function and MRI evaluation (PRODIGE study, NCT02070224). Type II collagen-specific biomarker Coll2-1 and its nitrated form Coll2-1NO2 were directly measured in serum using immunoassays at baseline and after three, six and twelve months follow-up.

Results: S-Coll2-1 was significantly correlated with bursitis (r=0.29, P< 0.01), bone attrition (r=0.25, P=0.01), cysts (r=0.24, P=0.02) and cartilage (r=0.23, P=0.03) WORMS sub-scores for the whole joint as well as with the medial femorotibial joint sum score (r=0.26, P=0.01) and medial femorotibial joint cartilage (r=0.23, P=0.02). s-Coll2-1NO2 was correlated with WORMS total score (r=0.23, P=0.02), WORMS scores in the patellofemoral (r=0.23, P=0.02) and medial femorotibial compartments (r=0.21, P=0.03) and with osteophytes scores (r=0.27, P< 0.01). Baseline s-Coll2-1NO2 was higher in subjects with a pain worsening (426.4 pg/mL [278.04-566.95]) as compared to non-progressors (306.84 [200.37-427.84]) over one year (AUC=0.655, P=0.015).

Conclusion: Cartilage biomarkers s-Coll2-1 and s-Coll2-1NO2 are associated to several knee OA features quantified with WORMS scoring system on MRI. Serum values of Coll2-1NO2 are also associated to a worsening of target knee pain over one year. Coll2-1 and Coll2-1NO2, in association with other structural features, pain and function, could help at identifying OA phenotypes and patients at risk of OA worsening.


Disclosure: Y. Henrotin, Artialis SA, 1; A. Hick, Artialis SA, 3; B. Costes, Artialis SA, 3; A. Labasse, Artialis SA, 3; T. Conrozier, LABHRA, 2, 5; M. Malaise, None; Y. Maugars, None; F. Pelousse, SODIRAY, 1, 5; J. Lemaire, Sodiray, 3; C. Tits, DNAlytics, 3; T. Helleputte, DNAlytics, 1, 3; D. Loeuille, None.

To cite this abstract in AMA style:

Henrotin Y, Hick A, Costes B, Labasse A, Conrozier T, Malaise M, Maugars Y, Pelousse F, Lemaire J, Tits C, Helleputte T, Loeuille D. Cartilage Biomarkers s-Coll2-1 and s-Coll2-1NO2 Are Associated with Knee Osteoarthritis MRI Features and Predict Disease Worsening [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/cartilage-biomarkers-s-coll2-1-and-s-coll2-1no2-are-associated-with-knee-osteoarthritis-mri-features-and-predict-disease-worsening/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cartilage-biomarkers-s-coll2-1-and-s-coll2-1no2-are-associated-with-knee-osteoarthritis-mri-features-and-predict-disease-worsening/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology